Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Selenium: A Cure for Autoimmune Thyroiditis
Volume: 21 Issue: 8
Author(s): Marco Giammanco*Manfredi Marco Giammanco
Affiliation:
- Department of Surgical, Oncological and Oral Sciences, Via Liborio Giuffrè, 5 90127 Palermo, University of Palermo,Italy
Keywords: Selenium, autoimmune thyroiditis, redox balance, pathological conditions and possible nutritional deficiencies.
Export Options
About this article
Cite this article as:
Giammanco Marco *, Giammanco Marco Manfredi , Selenium: A Cure for Autoimmune Thyroiditis, Endocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21 (8) . https://dx.doi.org/10.2174/1871530320666201014150147
DOI https://dx.doi.org/10.2174/1871530320666201014150147 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Endocannabinoid System in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Modulation of Collagen Turnover in Cardiovascular Disease
Current Pharmaceutical Design Systemic Involvement of IgG4-related Sclerosing Disease
Current Immunology Reviews (Discontinued) Quinone-Based Drugs: An Important Class of Molecules in Medicinal Chemistry
Medicinal Chemistry Breast Cancer: Understanding Sensitivity and Resistance to Chemotherapy and Targeted Therapies to Aid in Personalised Medicine
Current Cancer Drug Targets Anti-Inflammatory Drugs in the Treatment of Neurodegenerative Diseases: Current State
Current Pharmaceutical Design Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer
Current Pharmaceutical Biotechnology The Accomplices of NF-κB Lead to Radioresistance
Current Protein & Peptide Science The Marine Factor 3,5-dihydroxy-4-methoxybenzyl AlcoholSuppresses Cell Growth, Inflammatory Cytokine Production, andNF-κB Signaling-enhanced Osteoclastogenesis in In vitro MouseMacrophages RAW264.7 Cells
Current Molecular Medicine Role of the Gut Microbiota in Age-Related Chronic Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Electrochemotherapy: Progress and Prospects
Current Pharmaceutical Design Identification of a Novel Glutathione Conjugate of Diclofenac by LTQOrbitrap
Drug Metabolism Letters Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulationby Natural Products
Current Topics in Medicinal Chemistry Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis
Current Pharmaceutical Design Polyphenols-Rich Natural Products for Treatment of Diabetes
Current Medicinal Chemistry Rosuvastatin Induced Rhabdomyolysis in a Low Risk Patient: A Case Report and Review of the Literature
Current Clinical Pharmacology Vitamins Mediate Immunological Homeostasis and Diseases at the Surface of the Body
Endocrine, Metabolic & Immune Disorders - Drug Targets Pityriasis Rosea: An Updated Review
Current Pediatric Reviews Transglutaminase-Catalyzed Reactions Responsible for the Pathogenesis ofCeliac Disease and Neurodegenerative Diseases: From Basic Biochemistry to Clinic
Current Medicinal Chemistry Bevacizumab for Malignant Brain Gliomas. Which is the Current Evidence?
Recent Patents on Inflammation & Allergy Drug Discovery